[HTML][HTML] A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation—part 4: systematic review of …
Background Clinical decision-making for patients with stage I lung cancer is complex. It
involves multiple options [lobectomy, segmentectomy, wedge, stereotactic body …
involves multiple options [lobectomy, segmentectomy, wedge, stereotactic body …
UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy
P Diez, GG Hanna, KL Aitken, N Van As, A Carver… - Clinical Oncology, 2022 - Elsevier
The use of stereotactic ablative radiotherapy (SABR) in the UK has expanded over the past
decade, in part as the result of several UK clinical trials and a recent NHS England …
decade, in part as the result of several UK clinical trials and a recent NHS England …
Radiation Therapy for Lung Cancer: Imaging Appearances and Pitfalls
D Toussie, LA Ginocchio, BT Cooper… - Clinics in Chest …, 2024 - chestmed.theclinics.com
Lung cancer is the third most common cancer in the United States after breast and prostate
cancer and the leading cause of cancer-related death. 1 The overall 5-year survival rate …
cancer and the leading cause of cancer-related death. 1 The overall 5-year survival rate …
Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b;≤ 20 mm) NSCLC Treated by …
Introduction We aimed to compare outcomes of patients with first primary clinical T1a-
bN0M0 NSCLC treated with surgery or stereotactic body radiation therapy (SBRT). Methods …
bN0M0 NSCLC treated with surgery or stereotactic body radiation therapy (SBRT). Methods …
Quality of life after VATS lung resection and SABR for early-stage non-small cell lung cancer: a longitudinal study
Introduction Video-assisted thoracoscopic (VATS) lung resection is the recommended
curative treatment for early-stage non-small cell lung cancer (NSCLC). Patients considered …
curative treatment for early-stage non-small cell lung cancer (NSCLC). Patients considered …
[HTML][HTML] Stereotactic body radiation therapy for stage I medically operable non-small cell lung cancer
E Kocak Uzel, M Bagci Kilic, H Morcali, O Uzel - Scientific Reports, 2023 - nature.com
Stereotactic ablative body radiation therapy (SBRT) has emerged as the standard treatment
for inoperable patients with stage I non-small cell lung cancer (NSCLC). In the current study …
for inoperable patients with stage I non-small cell lung cancer (NSCLC). In the current study …
Age-related treatment patterns for stage I NSCLC in three European countries
Introduction Surgery is the preferred treatment for patients with early-stage non-small cell
lung cancer (NSCLC) while stereotactic body radiation therapy (SBRT) may be applied in …
lung cancer (NSCLC) while stereotactic body radiation therapy (SBRT) may be applied in …
The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy–a nationwide cohort …
JC de Ruiter, V van der Noort, JNA van Diessen… - Lung Cancer, 2024 - Elsevier
Objectives The aim of the Early-Stage LUNG cancer (ESLUNG) study was to compare
outcomes after minimally invasive lobectomy (MIL) and stereotactic ablative radiotherapy …
outcomes after minimally invasive lobectomy (MIL) and stereotactic ablative radiotherapy …
[HTML][HTML] Real-world impact of SABR on stage I non-small-cell lung cancer outcomes at a scottish cancer centre
M Stares, G Lewis, M Vallet, A Killean, G Tramonti… - Cancers, 2023 - mdpi.com
Simple Summary Surgery or conventional radical radiotherapy are established curative
treatment options for patients with localised, stage I non-small-cell lung cancer (NSCLC) …
treatment options for patients with localised, stage I non-small-cell lung cancer (NSCLC) …
[HTML][HTML] An International Registry Study of Early-Stage NSCLC treatment variations (LUCAEUROPE) in Europe and the USA highlighting variations
Abstract Objective Harmonized European NSCLC incidence, treatment approach, and
survival based on national tumor registries are unclear. Summary background data Surgery …
survival based on national tumor registries are unclear. Summary background data Surgery …